21 CFR §660.5
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
Each filling of the product shall be specific for antibody to hepatitis B surface antigen, as determined by specificity tests found acceptable by the Director, Center for Biologics Evaluation and Research.